Skip to main content
. 2023 Mar 27;11(2):e04052-22. doi: 10.1128/spectrum.04052-22

TABLE 1.

MIC values of common clinical antibiotics and FFA when used to treat COL-R Gram-negative bacteriac

MIC (μg/mL)
Antibiotic at the indicated MIC breakpoints (μg/mL) (S–R)b
ATM CAZ FEP IPM CIP LVX GEN TOB COL
Straina 8–32 8–32 8–32 2–8 0.5–2 1–4 4–16 4–16 2–4 FFA
QC
 ATCC 25922 0.06 0.12 0.016 0.06 0.008 0.008 0.5 1 1
 ATCC 27853 4 1 2 1 0.25 0.5 1 1 1
P. aeruginosa
 TL1671 8 4 8 2 0.25 1 2 1 32 >512
TL1736 4 4 2 16 1 1 32 8 8 >512
TL1744 32 32 16 16 32 8 ≥128 32 4 >512
 TL2314 16 32 16 4 0.5 2 8 2 8 >512
TL2917 32 16 16 16 0.25 2 8 8 8 >512
TL2967 128 16 32 16 8 16 8 8 4 >512
TL3008 4 2 4 16 0.5 1 16 4 32 >512
TL3086 128 16 16 ≥128 16 8 ≥128 128 32 >512
4–16 4–16 2–16 1–4 0.25–1 0.5–2 4–16 4–16 2–4
E. coli
DC90 ≥256 32 64 ≥256 64 32 ≥256 128 8 >512
DC3539 64 128 ≥128 0.5 64 16 128 128 8 >512
DC3599 64 16 8 1 4 8 16 8 8 >512
DC3806 64 64 16 1 4 8 16 16 8 >512
DC3846 128 64 ≥256 0.5 ≥256 128 ≥256 64 8 >512
DC4887 1 4 32 1 4 16 16 8 8 >512
DC5286 ≥256 128 ≥256 0.25 128 64 4 4 8 >512
DC7333 ≥256 ≥256 ≥256 16 ≥256 128 128 ≥256 4 >512
 
K. pneumoniae
FK169 ≥128 32 32 0.25 32 16 2 2 8 >512
FK1342 ≥128 ≥128 ≥128 0.25 1 0.5 1 4 ≥128 >512
FK1913 ≥128 ≥128 ≥128 32 ≥128 128 ≥128 ≥128 64 >512
 FK1986 0.0125 0.25 0.0125 0.25 0.0125 0.025 2 1 8 >512
FK3810 0.0125 128 ≥256 32 ≥256 128 ≥256 ≥256 64 >512
FK3994 ≥256 128 ≥256 32 ≥256 64 ≥256 ≥256 64 >512
FK6556 64 64 64 16 4 8 16 16 32 >512
FK6663 ≥256 ≥256 ≥256 32 ≥256 ≥256 ≥256 ≥256 16 >512
8–32 8–32 2–8 1–4 2–8 4–16 4–16 2–4
A. baumannii
BM1539 16 8 64 16 4 2 1 1 16 >512
BM1595 2 32 8 4 64 8 128 128 4 >512
BM2349 16 64 64 16 4 8 1 1 4 >512
BM2370 8 32 128 8 128 8 4 1 8 >512
BM2412 16 64 64 16 4 8 4 1 16 >512
BM2431 64 64 64 16 4 8 1 1 32 >512
BM2622 64 64 64 8 4 8 16 16 4 >512
a

Strains in boldface type are multidrug-resistant (MDR) strains.

b

Values in boldface type indicate resistance. S–R represents the susceptible (S) breakpoint to the resistant (R) breakpoint, according to CLSI supplement M100 (34) and EUCAST (49).

c

QC, quality control; ATM, aztreonam; CAZ, ceftazidime; FEP, cefepime; IMP, imipenem; CIP, ciprofloxacin; LVX, levofloxacin; GEN, gentamicin; TOB, tobramycin, COL, colistin; FFA, flufenamic acid.